Lamivudine Tablet, Film Coated
Product Images NDC 60687-720

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lamivudine (NDC 60687-720). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ahp72021

FDA Label Image

150 mg Lamivudine Tablet Blister (Blister)

150 mg Lamivudine Tablet Blister (Blister)
This is a list of Lamivudine tablets with different lot numbers, expiration dates, and strengths, ranging from 150mg to 10mg. No other information is available.*
FDA Label Image

150 mg Lamivudine Tablets Carton (Carton)

150 mg Lamivudine Tablets Carton (Carton)
This is a description of a drug package containing Lamivudine tablets. The tablets are film-coated, with each tablet containing 150 mg of the active ingredient. There are 30 tablets in the package, which is sealed and designed to keep the product at a temperature range of 20-25°C (68-77°F). The product is distributed by American Health Packaging in Columbus, Ohio. The recommended dosage is not provided in the package, and the customer can refer to the package insert for prescribing information. The package indicates that the drug product is from NDC 1 80505-251 and is for exclusive use by authorized personnel.*
FDA Label Image

Figure 1. Virologic Response Through Week 48, Epv20001 (intent-to-treat) (Figure1)

Figure 1. Virologic Response Through Week 48, Epv20001 (intent-to-treat) (Figure1)
This is a data table showing the proportion of patients with HIV who have RNA levels below 400 copies/mL after being treated with Lamivudine. The table provides information on the dosage and frequency of the Lamivudine treatment, as well as the duration of the treatment in weeks.*
FDA Label Image

Structural Formula (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.